Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Applied Postdoctoral Fellow

Artificial Intelligence · 2025-05-07

Processing Time
134 days
Decision Date
2025-05-07
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop AI-driven cancer diagnostics and personalized treatment tools using deep learning, generative models, and bioinformatics. His work focuses on building multimodal learning frameworks that merge genomic, histopathological, and clinical datasets to detect genetic signatures and treatment resistance in lung cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research targets pressing issues in cancer diagnostics and personalized treatment, aligning with U.S. precision medicine goals.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic productivity, including highly cited papers and NSF funding, demonstrates his capability to lead the research.

3 Balance of Interests Met

The benefit of advancing AI-driven healthcare solutions outweighs the requirement for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 journal articles, 5 abstracts, and 129 citations, with three papers ranking in the top 1% of their field. Evidence included 5 peer reviews for journals like IEEE Transactions on Medical Imaging and project funding from the National Science Foundation. The case was supported by two expert recommendation letters and satisfied all three Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE challenging all three prongs of the Dhanasar framework. The petitioner responded with expert letters and a narrative linking his publications and grants to national healthcare priorities.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
California 612 days 2025-08-21
The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.
View Case

Data Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
71 days 2025-01-04
The petitioner proposes to interrogate multimodal genomic and clinical datasets from cancer patients to uncover key associations between genetic traits, clinical features, and therapeutic responses. This work aims to enable the development of individualized cancer treatment strategies and reduce the financial and human burden of cancer in the U.S.
View Case

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Massachusetts 47 days 2025-02-06
The petitioner proposes to continue research in cancer precision medicine by leveraging omics-based data, including genomic, transcriptomic, and proteomic analyses. The work focuses on identifying clinically actionable biomarkers to develop personalized therapies and improve patient outcomes for those with cancer.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Artificial Intelligence cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 134 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist